Biomarkers of risk to develop lung cancer in the new screening era - Wikidata - awgldk - TriplyDB

Biomarkers of risk to develop lung cancer in the new screening era

Biomarkers of risk to develop lung cancer in the new screening era

http://www.wikidata.org/entity/Q26747784

about

Circulating and tissue biomarkers in early-stage non-small cell lung cancer The Pursuit of Noninvasive Diagnosis of Lung Cancer.Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer.Sputum-based DNA methylation biomarkers to guide lung cancer screening decisions.A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients.The narrow path to organized LDCT lung cancer screening programs in Europe

P2860

Q37629653-33EF37A0-16B6-4145-93BC-02657F0F4AF9 Q37652904-8C137207-E639-4886-8D94-7E82B31ECBA1 Q37710444-6BCF81E6-48A8-4300-A207-A1F47E57125F Q38733634-8E5EB9C4-A71E-4873-9D71-9E5BD5B8FDF0 Q47098424-67811547-4C9C-4873-AED1-D09B2E9B6528 Q47141129-3B6017E2-603A-4295-978D-14D5F94E42CD Q50294553-89129805-57FE-4251-99F8-24D213E5121A Q57178576-5CA336E8-0F0D-40D4-9FCC-57D8CB7F8DB6

P2860

Biomarkers of risk to develop lung cancer in the new screening era

http://www.wikidata.org/entity/Q26747784

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Biomarkers of risk to develop lung cancer in the new screening era

@ast

Biomarkers of risk to develop lung cancer in the new screening era

@en

Biomarkers of risk to develop lung cancer in the new screening era

@nl

type

label

Biomarkers of risk to develop lung cancer in the new screening era

@ast

Biomarkers of risk to develop lung cancer in the new screening era

@en

Biomarkers of risk to develop lung cancer in the new screening era

@nl

prefLabel

Biomarkers of risk to develop lung cancer in the new screening era

@ast

Biomarkers of risk to develop lung cancer in the new screening era

@en

Biomarkers of risk to develop lung cancer in the new screening era

@nl

P1433

Q26747784-790CE70A-6206-450C-96AB-4C679B20FA6C

P1476

Q26747784-9281BDA4-2651-4013-ABE5-DD603A201372

P2093

Q26747784-97CF30D4-532C-4A46-B7B1-2E1FDE4BDD3B

Q26747784-A78C4D61-B6AC-4C28-902A-3062899D4F59

P2860

Q26747784-0D91EF54-F0B5-4C64-AFD1-174783CB1163

Q26747784-1CA47FD1-6474-48A2-9F37-A392A7AA3ED7

Q26747784-1D158514-5B97-49A3-8B39-308B0A893D78

Q26747784-21A7D517-9956-4218-8AF4-A458668C60D3

Q26747784-24B7C510-8B9E-40E2-826B-3601871A2B7A

Q26747784-27F64CD2-0424-42AE-B89C-EA04CEE3C6CF

Q26747784-312FDA83-FA34-48BA-A02E-918D28FBCC1C

Q26747784-3321C8AE-694F-4341-87C0-CAF0614E52BF

Q26747784-3AB14468-83C8-41F2-ABE4-B838E1FE84AF

Q26747784-3EE03C8E-46D7-42F3-93E0-A4A369FA7E1D

P304

Q26747784-DB955018-7BB1-44A9-ACEB-5E4FDF5AB062

P31

Q26747784-90A0C34B-EC55-4522-A0D8-BB395F3C6CA7

P356

Q26747784-EC86D263-BDF3-432E-B844-594D948DADB8

P407

Q26747784-B23E16AA-E0A6-4089-9003-2180CDD65473

P433

Q26747784-98CF3DD8-2BDB-4D98-BF8F-3E6DC12F560C

P478

Q26747784-A3663C4B-324B-485B-A7B6-7AE077D71108

P577

Q26747784-11763D8D-49BD-444D-9E36-57E6917A0E62

P698

Q26747784-3061DA65-B5AE-4B4A-A1C1-E9C3B1F44BA5

P921

Q26747784-5A74B644-F950-4652-8676-225DEB6DEBDF

P932

Q26747784-599D3E8F-FE02-4C45-988F-3E78F9F22326

P356

P1433

Annals of translational medicine

P1476

Biomarkers of risk to develop lung cancer in the new screening era

@en

P2093

Pierre P Massion

http://www.w3.org/2001/XMLSchema#string

Thomas Atwater

http://www.w3.org/2001/XMLSchema#string

P2860

Lung cancer susceptibility model based on age, family history and genetic variants

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

Diagnostic and prognostic prediction models

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Reduced lung-cancer mortality with low-dose computed tomographic screening

A gene-based association method for mapping traits using reference transcriptome data

Extracting research-quality phenotypes from electronic health records to support precision medicine

Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

P304

158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2016.03.46

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27195276

http://www.w3.org/2001/XMLSchema#string

P921

P932

4860477

http://www.w3.org/2001/XMLSchema#string